SpicyIP Tidbit: Natco’s ‘compulsory licensing’ request to come up for hearing next week


IP Watch reports that Natco’s request for a compulsory license to export anti-cancer drugs to Nepal, is going to come up for hearing by the end of February. (Full story is available here) As most of our readers must know SpicyIP had covered this case extensively a couple of weeks ago. The request for compulsory licensing was made under S. 92A of the Patent Act, which allows for ‘compulsory licensing for export of patented pharmaceutical products in certain exceptional circumstances’….


Read More »

SpicyIP Tidbit: Search for Traditional Remedies for Bird Flu


In a major institutional boost towards applying traditional Indian medicine to modern day afflictions, the National Institute of Siddha (NIS), Chennai has announced that it would jointly work with six other institutions namely, University of Madras, Anna University, Dr. M.G.R.Medical University, King Institute, MadrasMedicalCollege and Tamil Nadu Veterinary and AnimalSciencesUniversity, in the fight against bird flu. In this connection, a day-long session was held at NIS on Microbiology, Virology and Clinical Parameters in Avian Flu (Siddha perspective). The details are…


Read More »

SpicyIP Tidbit: Bloopers Galore


Mysteriously, another form of Intellectual Property has cropped out of nowhere. Introducing the “Geographical Indicator Patent” also referred to as GIP. Atleast that is what The Telegraph says: “Pakistan opposes Jammu and Kashmir’s efforts to get a geographical indicator patent (GIP) on its centuries-old Sozni shawls, saying this embroidery craft is in vogue in its part of Kashmir, too. The neighbouring country’s traders want Sozni shawls made in Pakistan-occupied Kashmir included under the patent Kashmiri Sozni. Jammu and Kashmir’s Craft…


Read More »

SpicyIP Tidbit: “RIN”


Rural India, it appears, is telling its urban counterpart that it is time the latter caught up with it in terms of innovation. After NIF, we have another NGO helping rural innovators get their due. Rural Innovations Network (RIN), founded by a Mechanical engineer (cant help feeling proud of one of my brethren) Paul Basil, has lent itself to the cause of making commercially viable products out of rural innovations. The primary areas of RIN’s focus are innovations related to…


Read More »
Patent

SpicyIP Tidbits: Patent Cause List


Here’s a case involving the “Loins of Punjab”. New Delhi-based Enkay Rubber Co. which manufactures bladder shells for inflatable balls including soccer balls has alleged infringement of its US Patents 6,544,608 B1 and 6,949,276 B2 by Score American Soccer Co., Uniroyal Goodrich and Michelin N.A. According to the former, the defendants imported certain soccer balls, including the Jupiter soccer ball, from Sports Syndicate and Hans Raj Mahajan & Sons from Punjab, which infringe claims of the patents. The case has…


Read More »
Patent

SpicyIP Tidbit: Ranbaxy’s Dutch Challenge “Pfizzes” Out


Taking a cue from the late Saddam Hussain’s (or is it Hossein to faithfully toe CNN’s line?) (in)famous phrase, “the mother of all wars”, it appears that the Lipitor patent challenge is being touted as “the mother of all patent challenges”. Pfizer’s Lipitor is a cholesterol-lowering drug and Ranbaxy’s bid to challenge Pfizer’s Dutch patent on basic lipitor (EP 247633) received a setback with the High Court in the Netherlands, affirming the District Court judgment of 2006, byupholding the validity…


Read More »
Patent

Patent-ly problematic


India’s IP regime is being hauled up for not being industry friendly enough by the biotechnology Industry Association (BIA). Business Standard reports – The association raised the following concerns: 1. Indian laws lack clarity with regard to the patentability of biomolecules like nucleic acids.2. The provisions dealing with disallowing patents for known products which do not result in significant enhancement of efficacy.3. India’s capacity to include data protection clauses for medicines.4. The “onerous” obligations relating to the disclosure of source…


Read More »

Spicy Tidbits: Compulsory Licensing Dilemma


Bangkok is continuing preparations to import the generic drug to treat breast and lung cancer patients to fulfill its obligations under the universal health care scheme. This is despite the uncertainty over compulsory licensing in the country. The Government Pharmaceutical Organisation board has chosen to sign a deal with Dabur Pharma to distribute Docetaxel. The GPO chose the Indian drug maker over two other companies, including patent owner Sanofi Aventis, after it offered to distribute the drug for 1,245 baht…


Read More »
Patent

SpicyIP Tidbit: Patent Progress Report


No matter how much we try to extol the virtues of a qualitative analysis, none can deny the relevance and significance of a quantitative evaluation, for numbers speak for themselves or atleast the common man presumes them to do so. The editor of Intellectual Asset Magazine (IAM), Joff Wild, has come up with a “Patent Focus Report for 2008” for Thomson’s Knowledge Newsletter. According to this report: “The patent office is struggling to cope as applications rise. Despite the increased…


Read More »

SpicyIP Events: NLSIU to hold a National Symposium on Challenges to India’s Patent Regime on the 12th and 13th of April


The National Law School of India University (NLSIU), Bangalore is going to hold a National Symposium on Challenges to India’s Patent Regime on the 12th and 13th of April, 2008. The symposium is being organized by the Editorial Board of the National Law School of India Review (NLSIR) – NLS’s flagship journal formerly known as the Student Bar Review. The website can be accessed here. The concept note for the Symposium is available here. As per the website of the…


Read More »